Doseology Sciences Inc.
Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distribut… Read more
Market Cap & Net Worth: Doseology Sciences Inc. (DOSEF)
Doseology Sciences Inc. (OTCQB:DOSEF) has a market capitalization of $761.10K ($761.10K) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #48298 globally and #14853 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Doseology Sciences Inc.'s stock price $0.10 by its total outstanding shares 8011621 (8.01 Million).
Doseology Sciences Inc. Market Cap History: 2022 to 2025
Doseology Sciences Inc.'s market capitalization history from 2022 to 2025. Data shows change from $1.80 Million to $761.10K (-49.79% CAGR).
Doseology Sciences Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Doseology Sciences Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
17.88x
Doseology Sciences Inc.'s market cap is 17.88 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.80 Million | $16.05K | -$1.94 Million | 112.33x | N/A |
| 2023 | $1.79 Million | $43.09K | -$1.78 Million | 41.65x | N/A |
| 2024 | $3.98 Million | $98.52K | -$339.85K | 40.43x | N/A |
| 2025 | $761.10K | $42.56K | -$447.79K | 17.88x | N/A |
Competitor Companies of DOSEF by Market Capitalization
Companies near Doseology Sciences Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to Doseology Sciences Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Doseology Sciences Inc. Historical Marketcap From 2022 to 2025
Between 2022 and today, Doseology Sciences Inc.'s market cap moved from $1.80 Million to $ 761.10K, with a yearly change of -49.79%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $761.10K | -80.89% |
| 2024 | $3.98 Million | +121.96% |
| 2023 | $1.79 Million | -0.44% |
| 2022 | $1.80 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Doseology Sciences Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $761.10K USD |
| MoneyControl | $761.10K USD |
| MarketWatch | $761.10K USD |
| marketcap.company | $761.10K USD |
| Reuters | $761.10K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.